Nuclear and cytoplasmic expressions of ERβ1 and ERβ2 are predictive of response to therapy and alters prognosis in familial breast cancers - Yan, M; Rayoo, M; Takano, EA; Fox, SB (Breast Cancer Res Treat, 2011)
; kConFab Investigators.